European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives

Autoři	VALENT Peter HARTMANN Karin BONADONNA Patrizia SPERR Wolfgang NIEDOSZYTKO Marek KLUIN-NELEMANS Hanneke C HERMINE Olivier SOTLAR Karl HOERMANN Gregor NEDOSZYTKO Boguslaw BROESBY-OLSEN Sigurd ZANOTTI Roberta LANGE Magdalena DOUBEK Michael BROCKOW Knut ALVAREZ-TWOSE Ivan VARKONYI Judit YAVUZ Selim NILSSON Gunnar RADIA Deepti GRATTAN Clive SCHWAAB Juliana GILLEN Theo ELBERINK Hanneke N G Oude HAEGGLUND Hans SIEBENHAAR Frank HADZIJUSUFOVIC Emir SABATO Vito MAYER Jiří REITER Andreas ORFAO Alberto HORNY Hans-Peter TRIGGIANI Massimo AROCK Michel
Rok publikování	2023
Druh	Článek v odborném periodiku
Časopis / Zdroj	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
www	https://www.sciencedirect.com/science/article/pii/S2213219823002258?via%3Dihub
Doi	http://dx.doi.org/10.1016/j.jaip.2023.02.021
Klíčová slova	Mast cells; Mastocytosis; Mast cell activation dis-orders; MCAS; ECNM
Popis	In 2002, the European Competence Network on Mastocytosis (ECNM) was launched as a multidisciplinary collaborative initiative to increase the awareness and to improve diagnosis and management of patients with mast cell (MC) disorders. The ECNM consists of a net of specialized centers, expert physicians, and scientists who dedicate their work to MC diseases. One essential aim of the ECNM is to timely distribute all available information about the disease to patients, doctors, and scientists. In the past 20 years, the ECNM has expanded substantially and contributed successfully to the development of new diagnostic concepts, and to the classification, prognostication, and treatments of patients with mastocytosis and MC activation disorders. The ECNM also organized annual meetings and several working conferences, thereby supporting the license (http://creativecommons.org/licenses/by/4.0/). (J Al-Clin Immunol Pract 2023;11:1706-17)